MetaCap

Cibus Inc. Class A (CBUS)

NASDAQ: CBUSIndustrialsAgricultural ChemicalsUSD

1.21-0.02 (-1.63%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CBUS stock chart

Technical analysis

Key statistics

All statistics
Market cap
$92.73M
EPS (TTM)
-$1.46
52-week range
1.02 – 4.19
Day range
1.21 – 1.30
Volume / Avg
65.91K / 117.21K
Beta
—

52-week range

$1.02$4.19

CBUS stock today

On Nov 20, CBUS ended the session at $1.21, shedding $0.02 (1.63%), versus the S&P 500's 3.70% decline. Shares are 71.1% below their 52-week high of $4.19, set on Mar 11, 2026 and 19.1% above the 52-week low of $1.02, near the bottom of the past year's range. CBUS is down 30.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 4.0%.

Cibus has posted a net loss over the last twelve months (EPS of -$1.46), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Cibus

Company profile

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients.

Industry
Agricultural Chemicals
CEO
Mr. Craig Wichner
Headquarters
San Diego, CA
Employees
118
IPO year
2017
Website
cibus.com

Financial highlights

Full financials

In fiscal 2025, Cibus generated $3.6 million in revenue, down 14.6% from fiscal 2024, its first annual decline since 2022. Cibus reported a net loss of $127.1 million, compared with a loss of $251.4 million a year earlier. Operating margin was -2680.1%.

Cibus annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$3.64M$4.26M$1.82M$157.00K$25.99M
Growth-14.62%+134.56%+1057.32%-99.40%+8.96%
Net income$-127.08M$-251.39M$-267.63M$-16.89M$-29.20M
EPS (diluted)$-2.78$-10.83$-25.95$-18.36$-0.78

Analyst forecast

Forecast

Consensus (3 analysts)

buy

Avg. price target

$12.00+891.74%

  • Strong buy 0
  • Buy 2
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $2.00High $25.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-0.29 vs $-0.27
Surprise
-7.41%

CBUS news

All CBUS news

Cibus peers

Industrials sector
CBUS peer companies
CompanyPrice% ChgMarket capCompare
AVDAmerican Vanguard Corporation0.68-1.48%$20.10Mvs CBUS
BIOXBioceres Crop Solutions Corp.0.173-5.41%$11.04Mvs CBUS
FRTTFort Technology Inc.0.47-9.79%$7.14Mvs CBUS
EVGNEvogene Ltd0.3162+1.02%$5.71Mvs CBUS
SNESSenesTech Inc.0.69+6.15%$4.71Mvs CBUS
NXTSNexentis Technologies Inc.1.58-7.06%$1.05Mvs CBUS
ICLICL Group Ltd.4.08-1.45%—vs CBUS
UANCVR Partners LP95.09-0.88%—vs CBUS

Indexes, lists and sector

Cibus stock FAQ

What is Cibus's stock price today?

CBUS last traded at $1.21 as of Nov 20, 4:00 PM EST, down 1.63% on the day. Prices are delayed at least 15 minutes.

Does Cibus pay a dividend?

No. Cibus does not currently pay a regular cash dividend.

Who is Cibus's CEO?

Mr. Craig Wichner is the chief executive officer of Cibus Inc. Class A, which has about 118 employees.

Has CBUS ever split its stock?

Yes. The most recent CBUS stock split was a 1-for-5 split on Jun 1, 2023, one of 2 splits on record.

What is the CBUS 52-week high?

The 52-week high for CBUS is $4.19 and the 52-week low is $1.02. The stock is currently 71.1% below its high.

Compare CBUS